Last update Sept. 19, 2016
Very Low Risk
We do not have alternatives for Flecainide Acetate since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Flecainide Acetate in other languages or writings:
|Protein Binding||40 - 50||%|
|Tmax||3 - 4.5||hours|
|T½||7 - 22||hours|
|M/P ratio||2.6 - 3.7||-|
|Theoretical Dose||0.02 - 0.23||mg/Kg/d|
|Relative Dose||0.3 - 7||%|
|Ped.Relat.Dose||0.25 - 5.8||%|
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Although it is concentrated in the milk, the theoretical dose ingested by the infant does not reach 6% of the therapeutic dose (Wagner 1990, McQuinn 1990), even with a maternal dose as high as 200 mg daily.
American Academy of Pediatrics: medication usually compatible with breastfeeding.